Home
About
Overview
Sharing Data
ORCID
Help
History (52)
Propionigenium
Examining the Relationship Between Delay Discounting, Delay Aversion, Diabetes Self-care Behaviors, and Diabetes Outcomes in U.S. Adults With Type 2 Diabetes.
Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
A Distinction Without a Difference? A Multi-Method Approach to Understanding PTSD and Depression Symptom Overlap Among Disaster-Exposed Adolescents.
The story of glutamate in drug addiction and of N-acetylcysteine as a potential pharmacotherapy.
See All 52 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The story of glutamate in drug addiction and of N-acetylcysteine as a potential pharmacotherapy.
The story of glutamate in drug addiction and of N-acetylcysteine as a potential pharmacotherapy. JAMA Psychiatry. 2013 Sep; 70(9):895-7.
View in:
PubMed
subject areas
Acetylcysteine
Animals
Brain
Clinical Trials as Topic
Disease Models, Animal
Glutamic Acid
Receptors, Glutamate
Substance-Related Disorders
authors with profiles
Peter W Kalivas